{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:25:19Z","timestamp":1770416719795,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.drugalcdep.2017.02.021","type":"journal-article","created":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T01:02:40Z","timestamp":1494378160000},"page":"55-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder"],"prefix":"10.1016","volume":"176","author":[{"given":"Eugenia","family":"Oviedo-Joekes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Brissette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphne","family":"Guh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Marchand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salima","family":"Jutha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Janmohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek Z.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aslam H.","family":"Anis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Krausz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin T.","family":"Schechter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/bcp.12051","article-title":"Pharmacological maintenance treatments of opiate addiction","volume":"77","author":"Bell","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0010","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMra023160","article-title":"Drug addiction","volume":"349","author":"Cami","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0015","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/add.12551","article-title":"The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study","volume":"109","author":"Degenhardt","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000369337","article-title":"Efficacy of heroin-assisted treatment in belgium: a randomised controlled trial","volume":"21","author":"Demaret","year":"2015","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2125.2012.04317.x","article-title":"Differences between opioids: pharmacological, experimental, clinical and economical perspectives","volume":"75","author":"Drewes","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0030","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence","volume":"41","author":"Eap","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0035","series-title":"New Heroin-Assisted Treatment. Recent Evidence And Current Practices Of Supervised Injectable Heroin Treatment In Europe And Beyond","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2011"},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0040","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/aje\/kwg209","article-title":"Longitudinal patterns of drug injection behavior in the ALIVE Study cohort,1988-2000: Description and determinants","volume":"158","author":"Galai","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0045","first-page":"CD004145","article-title":"Substitution treatment of injecting opioid users for prevention of HIV infection","author":"Gowing","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1192\/bjp.bp.106.026112","article-title":"Heroin-assisted treatment for opioid dependence: randomised controlled trial","volume":"191","author":"Haasen","year":"2007","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jsat.2014.05.012","article-title":"Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence","volume":"47","author":"Hammig","year":"2014","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0060","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpsyc.58.5.503","article-title":"A 33-year follow-up of narcotics addicts","volume":"58","author":"Hser","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0065","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/0193841X07307315","article-title":"Trajectories of heroin addiction: growth mixture modeling results based on a 33-year follow-up study","volume":"31","author":"Hser","year":"2007","journal-title":"Eval. Rev."},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0070","series-title":"Clinical Safety Data Management: Definitions and Standards for Expedite Reporting \u2013 ICH Topic E2A","author":"International Council for Harmonization","year":"1994"},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.12.021","article-title":"Opioid substitution therapy: lowering the treatment thresholds","volume":"161","author":"Kourounis","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jsat.2006.04.007","article-title":"Controlled trial of prescribed heroin in the treatment of opioid addiction","volume":"31","author":"March","year":"2006","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000088581","article-title":"Drugs and social exclusion in ten European cities","volume":"12","author":"March","year":"2006","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0090","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0095","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0100","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s11524-008-9312-9","article-title":"The North American Opiate Medication Initiative (NAOMI): profile of participants in North America\u2019s first trial of heroin-assisted treatment","volume":"85","author":"Oviedo-Joekes","year":"2008","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0105","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa0810635","article-title":"Diacetylmorphine versus methadone for the treatment of opioid addiction","volume":"361","author":"Oviedo-Joekes","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0110","first-page":"1015","article-title":"History of treatment access and drug use among participants in a trial testing injectable opioids under supervision for long-term heroin injectors","volume":"3","author":"Oviedo-Joekes","year":"2015","journal-title":"J. Addict. Med. Ther."},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0115","first-page":"1","article-title":"The SALOME study: recruitment experiences in a clinical trial offering injectable diacetylmorphine and hydromorphone for opioid dependency","volume":"3","author":"Oviedo-Joekes","year":"2015","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0120","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jamapsychiatry.2016.0109","article-title":"Hydromorphone compared with diacetylmorphine for long-term opioid dependence: a randomized clinical trial","volume":"73","author":"Oviedo-Joekes","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0125","doi-asserted-by":"crossref","unstructured":"Oviedo-Joekes, E., Guh, D., Brissette, S., Marchand, K., MacDonald, S., Lock, K., Harrison, S., Janmohamed, A., Anis, A.H., Krausz, M., Marsh, D.C., Schechter, M.T., 2016b. Hydromorphone compared with diacetylmorphine for long-term opioid dependence: a randomized clinical trial \u2013 trial protocol. Available at: http:\/\/jamanetwork.com\/data\/Journals\/PSYCH\/935259\/YOI160008supp2_prod.pdf.","DOI":"10.1001\/jamapsychiatry.2016.0109"},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0130","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2215-0366(15)00413-7","article-title":"Comparative safety of methadone and buprenorphine","volume":"2","author":"Saxon","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0135","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(10)60349-2","article-title":"Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial","volume":"375","author":"Strang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1192\/bjp.bp.114.149195","article-title":"Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addictiondagger","volume":"207","author":"Strang","year":"2015","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.02.021_bib0145","unstructured":"World Medical Association, 2016. Declaration of Helsinki ethical principles for medical research involving human subjects. https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/ (accessed May 5th 2017)."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617301886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617301886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T23:48:35Z","timestamp":1569282515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617301886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":29,"alternative-id":["S0376871617301886"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.02.021","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}